LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | barcode | cell_count | frac_dead | corpse_count | cell_count_dead | row | column | agent | concentration | role | timepoint | replicate | cell_line | dead_count | fraction_dead | cell_count__time0 | dead_count__time0 | cell_count__ctrl | dead_count__ctrl | fraction_dead__ctrl | increase_fraction_dead | GRvalue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neratinib | 180614_BG_02 | 16968 | 0.0164 | 21 | 258 | 5 | 15 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_1 | 279 | 0.0162 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00382 | 0.9976 |
| Neratinib | 180614_BG_02 | 18291 | 0.0179 | 24 | 304 | 9 | 8 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_2 | 328 | 0.0176 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00238 | 1.0331 |
| Neratinib | 180614_BG_02 | 17386 | 0.0227 | 37 | 358 | 13 | 12 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_3 | 395 | 0.0222 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00222 | 1.0091 |
| Neratinib | 180614_BG_03 | 16864 | 0.0164 | 69 | 209 | 4 | 21 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_4 | 278 | 0.0162 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00378 | 0.9947 |
| Neratinib | 180614_BG_03 | 17051 | 0.0157 | 43 | 226 | 8 | 16 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_5 | 269 | 0.0155 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00446 | 0.9999 |
| Neratinib | 180614_BG_03 | 17326 | 0.0185 | 68 | 254 | 11 | 4 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_6 | 322 | 0.0182 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00175 | 1.0074 |
| Neratinib | 180614_BG_04 | 16377 | 0.0226 | 97 | 275 | 4 | 7 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_7 | 372 | 0.0222 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00221 | 0.9811 |
| Neratinib | 180614_BG_04 | 16872 | 0.0229 | 125 | 265 | 4 | 16 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_8 | 390 | 0.0226 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00260 | 0.9950 |
| Neratinib | 180614_BG_04 | 16566 | 0.0216 | 122 | 239 | 6 | 7 | Neratinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_9 | 361 | 0.0213 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00133 | 0.9864 |
| Neratinib | 180614_BG_02 | 17844 | 0.0193 | 43 | 303 | 6 | 9 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_1 | 346 | 0.0190 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00097 | 1.0214 |
| Neratinib | 180614_BG_02 | 16720 | 0.0134 | 11 | 213 | 7 | 21 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_2 | 224 | 0.0132 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00678 | 0.9907 |
| Neratinib | 180614_BG_02 | 16951 | 0.0194 | 39 | 291 | 14 | 20 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_3 | 330 | 0.0191 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00090 | 0.9972 |
| Neratinib | 180614_BG_03 | 16735 | 0.0209 | 81 | 271 | 3 | 9 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_4 | 352 | 0.0206 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00060 | 0.9912 |
| Neratinib | 180614_BG_03 | 17466 | 0.0175 | 61 | 246 | 8 | 7 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_5 | 307 | 0.0173 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00272 | 1.0112 |
| Neratinib | 180614_BG_03 | 17086 | 0.0194 | 58 | 275 | 14 | 14 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_6 | 333 | 0.0191 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00088 | 1.0009 |
| Neratinib | 180614_BG_04 | 17963 | 0.0194 | 90 | 261 | 5 | 5 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_7 | 351 | 0.0192 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00083 | 1.0245 |
| Neratinib | 180614_BG_04 | 17890 | 0.0242 | 146 | 291 | 9 | 12 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_8 | 437 | 0.0238 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00385 | 1.0226 |
| Neratinib | 180614_BG_04 | 16992 | 0.0211 | 122 | 239 | 14 | 22 | Neratinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_9 | 361 | 0.0208 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00081 | 0.9983 |
| Neratinib | 180614_BG_02 | 14112 | 0.0212 | 43 | 257 | 5 | 8 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_1 | 300 | 0.0208 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00082 | 0.9131 |
| Neratinib | 180614_BG_02 | 14052 | 0.0206 | 47 | 243 | 6 | 12 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_2 | 290 | 0.0202 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00022 | 0.9112 |
| Neratinib | 180614_BG_02 | 14451 | 0.0170 | 32 | 214 | 7 | 18 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_3 | 246 | 0.0167 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00326 | 0.9238 |
| Neratinib | 180614_BG_03 | 16319 | 0.0161 | 47 | 216 | 4 | 5 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_4 | 263 | 0.0159 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00413 | 0.9794 |
| Neratinib | 180614_BG_03 | 16545 | 0.0242 | 78 | 325 | 5 | 10 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_5 | 403 | 0.0238 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00378 | 0.9858 |
| Neratinib | 180614_BG_03 | 17919 | 0.0179 | 46 | 275 | 13 | 3 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_6 | 321 | 0.0176 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00240 | 1.0233 |
| Neratinib | 180614_BG_04 | 16535 | 0.0203 | 148 | 191 | 4 | 9 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_7 | 339 | 0.0201 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00009 | 0.9855 |